• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体趋化作用作为肿瘤细胞通过间质流和自分泌CCR7信号传导归巢至淋巴管的一种机制。

Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling.

作者信息

Shields Jacqueline D, Fleury Mark E, Yong Carolyn, Tomei Alice A, Randolph Gwendalyn J, Swartz Melody A

机构信息

Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.

出版信息

Cancer Cell. 2007 Jun;11(6):526-38. doi: 10.1016/j.ccr.2007.04.020.

DOI:10.1016/j.ccr.2007.04.020
PMID:17560334
Abstract

CCR7 is implicated in lymph node metastasis of cancer, but its role is obscure. We report a mechanism explaining how interstitial flow caused by lymphatic drainage directs tumor cell migration by autocrine CCR7 signaling. Under static conditions, lymphatic endothelium induced CCR7-dependent chemotaxis of tumor cells through 3D matrices. However, interstitial flow induced strong increases in tumor cell migration that were also CCR7 dependent, but lymphatic independent. This autologous chemotaxis correlated with metastatic potential in four cell lines and was verified by visualizing directional polarization of cells in the flow direction. Computational modeling revealed that transcellular gradients of CCR7 ligand were created under flow to drive this response. This illustrates how tumor cells may be guided to lymphatics during metastasis.

摘要

CCR7与癌症的淋巴结转移有关,但其作用尚不清楚。我们报告了一种机制,解释了由淋巴引流引起的间质流如何通过自分泌CCR7信号传导引导肿瘤细胞迁移。在静态条件下,淋巴管内皮通过三维基质诱导肿瘤细胞的CCR7依赖性趋化作用。然而,间质流导致肿瘤细胞迁移显著增加,这也是CCR7依赖性的,但与淋巴管无关。这种自体趋化作用与四种细胞系的转移潜能相关,并通过观察细胞在流动方向上的定向极化得到证实。计算模型显示,在流动条件下会产生CCR7配体的跨细胞梯度以驱动这种反应。这说明了肿瘤细胞在转移过程中可能是如何被引导至淋巴管的。

相似文献

1
Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling.自体趋化作用作为肿瘤细胞通过间质流和自分泌CCR7信号传导归巢至淋巴管的一种机制。
Cancer Cell. 2007 Jun;11(6):526-38. doi: 10.1016/j.ccr.2007.04.020.
2
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.肿瘤细胞与淋巴管相互作用中的血管内皮生长因子-C和C-C趋化因子受体7促进侵袭性表型。
Cancer Res. 2009 Jan 1;69(1):349-57. doi: 10.1158/0008-5472.CAN-08-1875.
3
Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma.CC趋化因子受体7与食管鳞状细胞癌淋巴结转移的相关性
Clin Cancer Res. 2003 Aug 15;9(9):3406-12.
4
CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.CCL21在体外促进高淋巴结转移人非小细胞肺癌Lu-99的迁移和黏附。
Oncol Rep. 2007 Jun;17(6):1511-6.
5
Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.趋化因子受体CCR7和CXCR3的表达与肺腺癌淋巴结转移潜能之间的关联
Oncol Rep. 2008 Jun;19(6):1461-8.
6
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.趋化因子受体7激活头颈部癌细胞中磷酸肌醇-3激酶介导的侵袭和促生存信号通路,且不依赖表皮生长因子受体。
Oncogene. 2005 Sep 1;24(38):5897-904. doi: 10.1038/sj.onc.1208740.
7
Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.趋化因子受体CCR7在甲状腺癌中的表达及功能
J Endocrinol. 2006 Oct;191(1):229-38. doi: 10.1677/joe.1.06688.
8
CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.CCR7通过高内皮微静脉介导Foxp3 +调节性T细胞迁移至外周淋巴结的副皮质区。
J Leukoc Biol. 2007 Nov;82(5):1230-8. doi: 10.1189/jlb.0906574. Epub 2007 Aug 14.
9
Prognostic value of CCR7 expression in gastric cancer.CCR7表达在胃癌中的预后价值。
Hepatogastroenterology. 2007 Jun;54(76):1025-8.
10
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.功能性CCR7趋化因子受体的表达可抑制恶性小鼠乳腺癌细胞转移的血管内侵入后步骤。
Oncol Rep. 2007 Aug;18(2):451-6.

引用本文的文献

1
Generation of stable advective-diffusive chemokine gradients in a three-dimensional hydrogel.在三维水凝胶中生成稳定的平流扩散趋化因子梯度。
AIP Adv. 2022 Feb 16;12(2). doi: 10.1063/5.0064947. eCollection 2022 Feb 1.
2
eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment.真核生物延伸因子2激酶(eEF2K)是胰腺癌中一个预后不良的因素和新的分子靶点:通过肿瘤微环境调节肿瘤生长和进展。
Cell Death Dis. 2025 Jul 7;16(1):501. doi: 10.1038/s41419-025-07803-w.
3
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.
肿瘤免疫调节中的细胞外基质动态变化:从肿瘤微环境到免疫治疗
J Hematol Oncol. 2025 Jun 19;18(1):65. doi: 10.1186/s13045-025-01717-y.
4
Cancer-on-a-chip for precision cancer medicine.用于精准癌症医学的芯片上的癌症模型
Lab Chip. 2025 May 16. doi: 10.1039/d4lc01043d.
5
Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression.食管癌肿瘤微环境中的趋化因子及其受体:转移和进展的关键因素
Front Oncol. 2025 Mar 11;15:1523751. doi: 10.3389/fonc.2025.1523751. eCollection 2025.
6
Autologous gradient formation under differential interstitial fluid flow environments.在不同的组织间液流动环境下的自体梯度形成。
Biophysica. 2022 Mar;2(1):16-33. doi: 10.3390/biophysica2010003. Epub 2022 Jan 4.
7
Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy.揭示生物力学在开拓癌症治疗创新策略方面的潜力。
Theranostics. 2025 Feb 10;15(7):2903-2932. doi: 10.7150/thno.108605. eCollection 2025.
8
Transient Lymphatic Remodeling Follows Sub-Ablative High-Frequency Irreversible Electroporation Therapy in a 4T1 Murine Model.在4T1小鼠模型中,亚消融性高频不可逆电穿孔治疗后出现短暂性淋巴管重塑。
Ann Biomed Eng. 2025 May;53(5):1148-1164. doi: 10.1007/s10439-024-03674-y. Epub 2025 Feb 25.
9
Inflammation in cancer: therapeutic opportunities from new insights.癌症中的炎症:新见解带来的治疗机遇
Mol Cancer. 2025 Feb 24;24(1):51. doi: 10.1186/s12943-025-02243-8.
10
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer.利用数学建模和人工智能提高癌症治疗的递送效率和疗效。
Nat Rev Cancer. 2025 May;25(5):324-340. doi: 10.1038/s41568-025-00796-w. Epub 2025 Feb 19.